Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct;19(10):2210-2213.e3.
doi: 10.1016/j.cgh.2021.05.060. Epub 2021 Jun 2.

COVID-19 Outcomes Among Racial and Ethnic Minority Individuals With Inflammatory Bowel Disease in the United States

Manasi Agrawal  1 , Erica J Brenner  2 , Joyce Wing Yan Mak  3 , Xian Zhang  4 , Gilaad G Kaplan  5 , Siew C Ng  3 , Walter Reinisch  6 , Flavio Steinwurz  7 , James D Lewis  8 , Michele Kissous-Hunt  9 , Irene Modesto  10 , Ryan C Ungaro  11 , Jean-Frederic Colombel  11 , Michael D Kappelman  2
Affiliations

COVID-19 Outcomes Among Racial and Ethnic Minority Individuals With Inflammatory Bowel Disease in the United States

Manasi Agrawal et al. Clin Gastroenterol Hepatol. 2021 Oct.

Abstract

The coronavirus disease 2019 (COVID-19) has affected more than 29 million people and led to more than 542,000 deaths in the United States.1 Older age, comorbidities, and racial and ethnic minority status are associated with severe COVID-19.2 Among patients with inflammatory bowel disease (IBD), racial and ethnic minorities have worse outcomes, mediated in part by inequitable health care access.3 Racial and ethnic minority patients with IBD and COVID-19 may be an especially vulnerable population. The purpose of this study was to evaluate racial and ethnic disparities in COVID-19 outcomes among IBD patients and the impact of non-IBD comorbidities on observed disparities.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Estimates of coronavirus disease 2019 (COVID-19) outcomes and 95% CIs by race and ethnicity from Surveillance Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease (SECURE-IBD) cases in the United States. (A) Odds ratios of hospitalization resulting from COVID-19 among Hispanic vs non-Hispanic white individuals and among non-Hispanic black vs non-Hispanic white individuals. (B) Odds ratios of severe COVID-19 outcomes (intensive care unit [ICU] stay, mechanical ventilation, or death) among Hispanic vs non-Hispanic white individuals and among non-Hispanic black vs non-Hispanic white individuals. BMI, body mass index; IL, interleukin; JAK, Janus kinase; 6-MP, 6-mercaptopurine; TNF, tumor necrosis factor.
See this image and copyright information in PMC

References

    1. Johns Hopkins University and Medicine CRC . Johns Hopkins University & Medicine; Baltimore, MD: 2020. COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU)
    1. Kirby T. Evidence mounts on the disproportionate effect of COVID-19 on ethnic minorities. Lancet Respir Med. 2020;8:547–548. - PMC - PubMed
    1. Barnes E.L., Loftus E.V., Jr., Kappelman M.D. Effects of race and ethnicity on diagnosis and management of inflammatory bowel diseases. Gastroenterology. 2021;160:677–689. - PubMed
    1. Brenner E.J., Ungaro R.C., Gearry R.B., et al. Corticosteroids, but not TNF antagonists, are associated with adverse COVID-19 outcomes in patients with inflammatory bowel diseases: results from an international registry. Gastroenterology. 2020;159:481–491.e3. - PMC - PubMed
    1. Price-Haywood E.G., Burton J., Fort D., et al. Hospitalization and mortality among black patients and white patients with covid-19. N Engl J Med. 2020;382:2534–2543. - PMC - PubMed

Publication types